Vorhandelsmarkt: .17 0.001 +0.59%

Glycomimetics Inc (GLYC)

Glycomimetics Inc Aktie (GLYC) Neueste Nachrichten

Glycomimetics Inc (GLYC)

Glycomimetics Inc Aktie (GLYC) Neueste Nachrichten

GlycoMimetics Inc [GLYC] Records 50-Day SMA of $0.1928 - Knox Daily

GLYC’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle

GlycoMimetics Inc [GLYC] Stock sold by Insider Invus Public Equities, L.P. for $50009.0 - Knox Daily

Capital One Initiates Coverage of GlycoMimetics (GLYC) with Overweight Recommendation - MSN

Market Insights: GlycoMimetics Inc (GLYC)’s Notable Drop of -0.18, Closing at 0.16 - The Dwinnex

Is GlycoMimetics Inc (GLYC) a threat to investors? - US Post News

GlycoMimetics Inc [NASDAQ: GLYC] Sees Decrease in Stock Value - Knox Daily

Analytical Lens: Exploring GlycoMimetics Inc (GLYC)’s Financial Story Through Ratios - The Dwinnex

India Glycols receives revision in credit rating from CARE - Business Standard

CARE Ratings affirms 'A-' rating of India Glycols with 'stable' outlook - Business Standard

StockNews.com Initiates Coverage on GlycoMimetics (NASDAQ:GLYC) - Defense World

Glycomine Receives FDA Fast Track Designation for GLM101 for the Treatment of PMM2-CDG - BioSpace

Galmed Pharmaceuticals Soars Nearly 500% Amid Nasdaq Compliance and Short Squeeze - TipRanks

Galmed Pharmaceuticals Surges 400%: What's Behind the Explosion? - MarketBeat

GlycoMimetics Inc [GLYC] Investment Appeal on the Rise - Knox Daily

Short Interest in GlycoMimetics, Inc. (NASDAQ:GLYC) Decreases By 16.5% - Defense World

TD Cowen’s latest rating for GLYC stock - Knox Daily

Closing Figures: GlycoMimetics Inc (GLYC)’s Negative Finish at 0.16, Down -2.82 - The Dwinnex

GlycoMimetics (NASDAQ:GLYC) Coverage Initiated at StockNews.com - Defense World

Wall Street analysts’ outlook for GlycoMimetics Inc (GLYC) - SETE News

GLYC’s Debt-to-Equity Ratio at 0.02: What It Means for GlycoMimetics Inc’s Future - The InvestChronicle

GlycoMimetics stock plunges to 52-week low of $0.16 - Investing.com

GlycoMimetics stock plunges to 52-week low of $0.16 By Investing.com - Investing.com UK

Trading Day Review: GlycoMimetics Inc (GLYC) Gains Momentum, Closing at 0.18 - The Dwinnex

GlycoMimetics Inc (GLYC) did well last session? - US Post News

GlycoMimetics (NASDAQ:GLYC) Research Coverage Started at StockNews.com - Defense World

GLYC Shares Experience Decline in Value - Knox Daily

GLYC’s Stock Dilemma: GlycoMimetics Inc’s Market Performance and Outlook - The InvestChronicle

Stocks of GlycoMimetics Inc (GLYC) are poised to climb above their peers - SETE News

GlycoMimetics Inc [GLYC] stock was sold by Invus Public Equities, L.P. at the price of US$50009.0 - Knox Daily

Balance Sheet Insights: GlycoMimetics Inc (GLYC)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

GlycoMimetics (NASDAQ:GLYC) Now Covered by Analysts at StockNews.com - Defense World

GlycoMimetics Inc [GLYC] 10% Owner makes an insider purchase of 260,873 shares worth 50009.0. - Knox Daily

GlycoMimetics Inc [GLYC] Is Currently 8.70 above its 200 Period Moving Avg: What Does This Mean? - The DBT News

Nothing is Better Than GlycoMimetics Inc (GLYC) stock at the moment - SETE News

GlycoMimetics Inc [GLYC] Investment Appeal on the Rise - Knoxdaily.com

GlycoMimetics Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle

GlycoMimetics Inc (GLYC)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex

A stock that deserves closer examination: GlycoMimetics Inc (GLYC) - US Post News

StockNews.com Begins Coverage on GlycoMimetics (NASDAQ:GLYC) - Defense World

Analyzing GlycoMimetics (NASDAQ:GLYC) and Fulcrum Therapeutics (NASDAQ:FULC) - Defense World

Taking a look at what insiders are doing to gauge the GlycoMimetics Inc (GLYC)’s direction - Knox Daily

Vanguard Group Inc. Raises Stake in GlycoMimetics, Inc. (NASDAQ:GLYC) - Defense World

GlycoMimetics Inc (GLYC) Stock: A Year of Stock Market Dynamics - The InvestChronicle

GlycoMimetics Inc (GLYC) Performance and Fundamentals Dashboard tells a completely different story - SETE News

Apollomics Reports First Half 2024 Financial Results and Highlights Vebreltinib Clinical Progress - GlobeNewswire Inc.

Potential Price Increase for GlycoMimetics Inc (GLYC) After Recent Insider Activity - Knoxdaily.com

GlycoMimetics stock plunges to 52-week low of $0.17 By Investing.com - Investing.com Australia

It would be worthwhile to take a closer look at GlycoMimetics Inc (GLYC) - US Post News

GlycoMimetics stock plunges to 52-week low of $0.17 - Investing.com

GlycoMimetics stock plunges to 52-week low of $0.17 By Investing.com - Investing.com UK

Quarterly Snapshot: Quick and Current Ratios for GlycoMimetics Inc (GLYC) - The Dwinnex

GlycoMimetics, Inc. (NASDAQ:GLYC) Major Shareholder Public Equities L.P. Invus Sells 61,488 Shares of Stock - Defense World

Invus entities sell over $61k in GlycoMimetics stock By Investing.com - Investing.com Australia

Invus entities sell over $61k in GlycoMimetics stock - Investing.com India

Invus entities sell over $61k in GlycoMimetics stock - Investing.com

10% Owner Invus Public Equities, L.P. sale 55,732 shares of GlycoMimetics Inc [GLYC] - Knox Daily

Public Equities L.P. Invus Sells 164,523 Shares of GlycoMimetics, Inc. (NASDAQ:GLYC) Stock - Defense World

Monitoring GlycoMimetics Inc (GLYC) after recent insider movements - Knox Daily

Can you now get a good deal on GlycoMimetics Inc’s shares? - US Post News

Public Equities L.P. Invus Sells 63,564 Shares of GlycoMimetics, Inc. (NASDAQ:GLYC) Stock - American Banking and Market News

GlycoMimetics, Inc. (NASDAQ:GLYC) Major Shareholder Public Equities L.P. Invus Sells 63,564 Shares of Stock - Defense World

GlycoMimetics Inc (GLYC)’s Market Momentum: Closing Strong at 0.20, Down -6.02 - The Dwinnex

GlycoMimetics stock plunges to 52-week low of $0.2 By Investing.com - Investing.com UK

GLYC Stock Sees Decline of Approximately -8.16% in Last Five Days - Knox Daily

Ähnlich wie GLYC